Feeding microstructure in diet-induced obesity susceptible versus resistant rats: Central effects of urocortin 2

Journal of Physiology

Volumn 583, Issue 2, 2007, Pages 487-504

  Cottone, Pietro ^a   Sabino, Valentina ^a   Nagy, Tim R ^b   Coscina, Donald V ^c   Zorrilla, Eric P ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; NEUROPEPTIDE; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN II; G PROTEIN COUPLED RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DOSE COMPARISON; DRUG POTENCY; FEEDING BEHAVIOR; FOOD COMPOSITION; FOOD INTAKE; GENETIC PREDISPOSITION; GENOTYPE; HEREDITY; HYPERPHAGIA; LATENT PERIOD; LEAN BODY WEIGHT; LIGHT DARK CYCLE; LOW FAT DIET; MALE; NONHUMAN; OBESITY; PREDICTION; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RISK FACTOR; SATIETY; ANALYSIS OF COVARIANCE; ANALYSIS OF VARIANCE; BODY COMPOSITION; BODY WEIGHT; CANNULATION; DIET INDUCED OBESITY; ENERGY BALANCE; ENERGY METABOLISM; ENTROPY; ENZYME ACTIVATION; HUMIDITY; HYPOTHALAMUS; PEPTIDERGIC NERVOUS SYSTEM; PROBABILITY; SENSITIVITY ANALYSIS; WEIGHT REDUCTION;

EID: 34548307260     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.138867     Document Type: Article

References (70)

1. Adan R (2002). Preface. Eur J Pharmacol 440, 83.
2. Arase K, Shargill NS & Bray GA (1989 a). Effects of corticotropin releasing factor on genetically obese (fatty) rats. Physiol Behav 45, 565-570.
3. Arase K, Shargill NS & Bray GA (1989 b). Effects of intraventricular infusion of corticotropin-releasing factor on VMH-lesioned obese rats. Am J Physiol Regul Integr Comp Physiol 256, R751-R756.
4. Bale TL, Anderson KR, Roberts AJ, Lee KF, Nagy TR & Vale WW (2003). Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology 144, 2580-2587.
5. Berteus Forslund H, Torgerson JS, Sjostrom L & Lindroos AK (2005). Snacking frequency in relation to energy intake and food choices in obese men and women compared to a reference population. Int J Obesity 29, 711-719.
6. Bradbury MJ, McBurnie MI, Denton DA, Lee KF & Vale WW (2000). Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology 141, 2715-2724.
7. Chapelot D, Aubert R, Marmonier C, Chabert M & Louis-Sylvestre J (2000). An endocrine and metabolic definition of the intermeal interval in humans: Evidence for a role of leptin on the prandial pattern through fatty acid disposal. Am J Clin Nutr 72, 421-431.
8. Clegg DJ, Benoit SC, Reed JA, Woods SC, Dunn-Meynell A & Levin BE (2005). Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am J Physiol Regul Integr Comp Physiol 288, R981-R986.
9. Cohn C, Joseph D, Bell L & Allweiss MD (1965). Studies on the effects of feeding frequency and dietary composition on fat deposition. Ann N Y Acad Sci 131, 507-518.
10. Comuzzie AG & Allison DB (1998). The search for human obesity genes. Science 280, 1374-1377.
11. Cottone P, Sabino V, Steardo L & Zorrilla EP (2007). FG 7142 Specifically reduces meal size and the rate and regularity of sustained feeding in female rats: Evidence that benzodiazepine inverse agonists reduce food palatability. Neuropsychopharmacology (in press).
12. Cruise J & Katz DL (2005). The Three-Hour Diet: How Low-Carb Diets Make You Fat and Timing Makes You Thin. Collins, New York, NY, USA.
13. Cullen MJ, Ling N, Foster AC & Pelleymounter MA (2001). Urocortin, corticotropin releasing factor-2 receptors and energy balance. Endocrinology 142, 992-999.
14. Daniels D, Markison S, Grill HJ & Kaplan JM (2004). Central structures necessary and sufficient for ingestive and glycemic responses to Urocortin I administration. J Neurosci 24, 11457-11462.
15. de Castro JM (1993 a). Genetic influences on daily intake and meal patterns of humans. Physiol Behav 53, 777-782.
16. de Castro JM (1993 b). Independence of genetic influences on body size, daily intake, and meal patterns of humans. Physiol Behav 54, 633-639.
17. de Krom M, van der Schouw YT, Hendriks J, Ophoff RA, van Gils CH, Stolk RP, Grobbee DE & Adan R (2007). Common genetic variations in CCK, leptin, and leptin receptor genes are associated with specific human eating patterns. Diabetes 56, 276-280.
18. Drazen DL & Woods SC (2003). Peripheral signals in the control of satiety and hunger. Curr Opin Clin Nutr Metab Care 6, 621-629.
19. Erlanson-Albertsson C & Zetterstrom R (2005). The global obesity epidemic: Snacking and obesity may start with free meals during infant feeding. Acta Paediatr 94, 1523-1531.
20. Farley C, Cook JA, Spar BD, Austin TM & Kowalski TJ (2003). Meal pattern analysis of diet-induced obesity in susceptible and resistant rats. Obesity Res 11, 845-851.
21. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA & O'Rahilly S (1999). Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341, 879-884.
22. Fekete EM, Inoue K, Zhao Y, Rivier JE, Vale WW, Szucs A, Koob GF & Zorrilla EP (2007). Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: Intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology 32, 1052-1068.
23. Fekete EM & Zorrilla EP (2007). Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs. Front Neuroendocrinol 28, 1-27.
24. Francis LA, Lee Y & Birch LL (2003). Parental weight status and girls' television viewing, snacking, and body mass indexes. Obesity Res 11, 143-151.
25. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA & Friedman JM (1997). Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A 94, 8878-8883.
26. Harris RB & Martin RJ (1984). Recovery of body weight from below 'set point' in mature female rats. J Nutrition 114, 1143-1150.
27. Heinrichs SC, Joppa M, Lapsansky J, Jeske K, Nelson R & De Souza E (2001). Selective stimulatory actions of corticotropin-releasing factor ligands on correlates of energy balance. Physiol Behav 74, 5-13.
28. Heinrichs SC, Lapsansky J, Behan DP, Chan RK, Sawchenko PE, Lorang M, Ling N, Vale WW & De Souza EB (1996). Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proc Natl Acad Sci U S A 93, 15475-15480.
29. Hoare SR, Sullivan SK, Fan J, Khongsaly K & Grigoriadis DE (2005). Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: Pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity. Peptides 26, 457-470.
30. Huang Q, Timofeeva E & Richard D (2006 a). Corticotropin-releasing factor and its receptors in the brain of rats with insulin and corticosterone deficits. J Mol Endocrinol 37, 213-226.
31. Huang Q, Timofeeva E & Richard D (2006 b). Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress. J Endocrinol 191, 179-188.
32. Inoue K, Valdez GR, Reyes TM, Reinhardt LE, Tabarin A, Rivier J, Vale WW, Sawchenko PE, Koob GF & Zorrilla EP (2003). Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. J Pharmacol Exp Ther 305, 385-393.
33. Irani BG, Dunn-Meynell AA & Levin BE (2007). Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity. Endocrinology 148, 310-316.
34. Jahn O, Tezval H, van Werven L, Eckart K & Spiess J (2004). Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity. Neuropharmacology 47, 233-242.
35. Kleiber M & Rogers TA (1961). Energy metabolism. Annu Rev Physiol 23, 5-36.
36. Levin BE & Dunn-Meynell AA (2002). Defense of body weight depends on dietary composition and palatability in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 282, R46-R54.
37. Levin BE, Dunn-Meynell AA, Balkan B & Keesey RE (1997). Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 273, R725-R730.
38. Levin BE, Dunn-Meynell AA & Banks WA (2004). Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol 286, R143-R150.
39. Levin BE, Dunn-Meynell AA, McMinn JE, Alperovich M, Cunningham-Bussel A & Chua SC Jr (2003). A new obesity-prone, glucose-intolerant rat strain (F.DIO). Am J Physiol Regul Integr Comp Physiol 285, R1184-R1191.
40. Makino S, Nishiyama M, Asaba K, Gold PW & Hashimoto K (1998). Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation. Am J Physiol Regul Integr Comp Physiol 275, R1138-R1145.
41. Mann PE, Pasternak GW, Hahn EF, Curreri G, Lubin E & Bodnar RJ (1988). Comparison of effects of chronic administration of naloxone and naloxonazine upon food intake and maintenance of body weight in rats. Neuropharmacology 27, 349-355.
42. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB & O'Rahilly S (1997). Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908.
43. Nicklas TA, Baranowski T, Cullen KW & Berenson G (2001). Eating patterns, dietary quality and obesity. J Am Coll Nutr 20, 599-608.
44. Niederau C, Meereis-Schwanke K, Klonowski-Stumpe H & Herberg L (1997). CCK-resistance in Zucker obese versus lean rats. Regul Pept 70, 97-104.
45. Nishiyama M, Makino S, Asaba K & Hashimoto K (1999). Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat. J Neuroendocrinol 11, 307-314.
46. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ & Flegal KM (2006). Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295, 1549-1555.
47. Ohata H, Arai K & Shibasaki T (2002). Effect of chronic administration of a CRF 1 receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress. Eur J Pharmacol 457, 201-206.
48. Ohata H & Shibasaki T (2004). Effects of urocortin 2 and 3 on motor activity and food intake in rats. Peptides 25, 1703-1709.
49. Parks EJ & McCrory MA (2005). When to eat and how often? Am J Clin Nutr 81, 3-4.
50. Paxinos G & Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
51. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW & Sawchenko PE (2001). Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 98, 2843-2848.
52. Ricci MR & Levin BE (2003). Ontogeny of diet-induced obesity in selectively bred Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 285, R610-R618.
53. Richard D, Lin Q & Timofeeva E (2002). The corticotropin-releasing factor family of peptides and CRF receptors: Their roles in the regulation of energy balance. Eur J Pharmacol 440, 189-197.
54. Richard D, Rivest R, Naimi N, Timofeeva E & Rivest S (1996). Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology 137, 4786-4795.
55. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Tache Y & Vale W (2002). Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 45, 4737-4747.
56. Rohner-Jeanrenaud F, Walker CD, Greco-Perotto R & Jeanrenaud B (1989). Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 124, 733-739.
57. Senn S (2006). Change from baseline and analysis of covariance revisited. Statistics Med 25, 4334-4344.
58. Shannon CE & Weaver W (1949). The Mathematical Theory of Communication. University of Illinois Press, Urbana.
59. Tabarin A, Dis-Chavez Y, Consoli D, Monsaingeon M, Bale TL, Culler M, Datta R, Drago F, Vale W, Koob GF, Zorrilla EP & Contarino A (2007). Role of the CRF receptor type 2 in the control of food intake in mice: A meal pattern analysis. Eur J Neurosci (in press).
60. Tolkamp BJ & Kyriazakis II (1999). To split behaviour into bouts, log-transform the intervals. Anim Behav 57, 807-817.
61. US Department of Agriculture Economic Research Service (1999). America's Eating Habits: Changes and Consequences, ed Frazzo E, Agriculture Information Bulletin No. AIB750. USDA Economic Research Service, Washington, DC (http://www.ers.usda.gov/Publications/AIB750/).
62. Vickers AJ (2001). The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study. BMC Med Res Methodol 1, 6.
63. Warwick ZS, Synowski SJ, Rice KD & Smart AB (2003). Independent effects of diet palatability and fat content on bout size and daily intake in rats. Physiol Behav 80, 253-258.
64. Westerterp-Plantenga MS, Saris WH, Hukshorn CJ & Campfield LA (2001). Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. Am J Clin Nutr 74, 426-434.
65. Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HL, Seal LJ, Ghatei MA & Bloom SR (2002). The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 76, 316-324.
66. Zizza C, Siega-Riz AM & Popkin BM (2001). Significant increase in young adults' snacking between 1977-1978 and 1994-96 represents a cause for concern! Prev Med 32, 303-310.
67. Zorrilla EP, Inoue K, Fekete EM, Tabarin A, Valdez GR & Koob GF (2005 a). Measuring meals: Structure of prandial food and water intake of rats. Am J Physiol Regul Integr Comp Physiol 288, R1450-R1467.
68. Zorrilla EP, Inoue K, Valdez GR, Tabarin A & Koob GF (2005 b). Leptin and post-prandial satiety: Acute central leptin more potently reduces meal frequency than meal size in the rat. Psychopharmacology 177, 324-335.
69. Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW & Koob GF (2004). Human urocortin 2, a corticotropin-releasing factor (CRF) 2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. J Pharmacol Exp Ther 310, 1027-1034.
70. Zorrilla EP, Tache Y & Koob GF (2003). Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends Pharmacol Sci 24, 421-427.